You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

ACTAVIS LLC Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?

ACTAVIS LLC has eight approved drugs.

There is one tentative approval on ACTAVIS LLC drugs.

Summary for ACTAVIS LLC

US Patents:	0
Tradenames:	6
Ingredients:	6
NDAs:	8
Patent Litigation for ACTAVIS LLC:	See patent lawsuits for ACTAVIS LLC
PTAB Cases with ACTAVIS LLC as petitioner:	See PTAB cases with ACTAVIS LLC as petitioner

Drugs and US Patents for ACTAVIS LLC

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Llc	DAPSONE	dapsone	TABLET;ORAL	204380-002	Mar 23, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Llc	LEVOLEUCOVORIN CALCIUM	levoleucovorin calcium	POWDER;INTRAVENOUS	208723-001	Sep 29, 2016		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Actavis Llc	METHYLNALTREXONE BROMIDE	methylnaltrexone bromide	SOLUTION;SUBCUTANEOUS	208112-002	Aug 26, 2024	AP	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Llc	FLUDARABINE PHOSPHATE	fludarabine phosphate	INJECTABLE;INJECTION	203738-001	Feb 28, 2017		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Llc	DAPSONE	dapsone	TABLET;ORAL	204380-001	Mar 23, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Actavis Llc	MELPHALAN HYDROCHLORIDE	melphalan hydrochloride	POWDER;INTRAVENOUS	209323-001	Mar 6, 2020		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.